China's CanSino says enrollment for Phase 3 trials of its COVID-19 vaccine hasn't begun

China’s CanSi Biologics, on August 18, said that it h t yet started enrolling participants for third phase trial of its potential COVID-19 vaccine 5-nCOV. Last month, vaccine company h revealed that it was in talks with Saudi Arabia, Russia, Brazil and Chile to launch last phase of trial for its vaccine candidate. However, Petrovax, a Russian pharmaceutical company recently confirmed that it would be running final trials in Russia.

study for phase three h alrey begun on Aug 14, Russian state register revealed. According to reports, at least 625 people are expected to be recruited to test safety and effectiveness of drug. However, CanSi said that it was currently working with several nations to start phase three trials as soon as possible. “As at date of this anuncement, enrolment of phase III clinical trial has t started,” it said. 

Re: China Grants First COVID-19 Vaccine Patent To CanSi Biologics' 'experimental Vaccine'

Country's first patent vaccine

China h previously approved vaccine for use by its military after early and mid-st trials, and furr late-st trials are being lined up for Mexico and Saudi Arabia. On August 18, vaccine, which is developed jointly by military's research unit and CanSi Biologics, was also granted patent.  " evirus vector vaccine candidate was found to be safe and able to trigger an immune response in first and second sts of clinical trials," reported state-sponsored media China Daily. As per  patent document published on website of National Intellectual Property ministration, application for newly issued patent was submitted on March 18, and was approved on Aug 11, China Daily reported.

Re: China Grants First COVID-19 Vaccine Patent To CanSi Biologics' 'experimental Vaccine'

Back on June 29, CanSi Biologics stated that clinical trials of vaccine proved to be safe and apparently, even efficient. According to an international media ncy, 5-nCoV is one of eight vaccine candidates that are currently being developed by China-based firms while global deaths have surpassed 7 lakh. It was also first vaccine to enter first-st clinical trials in China back in March at onset of global outbreak of Coronavirus.

Re: UK Govt Informs Over 1,00,000 People Volunteered For Coronavirus Vaccine Trials

Re: COVID-19 Vaccine: Govt Panel Meets Representatives Of Leing Domestic Manufacturers

Im credits: PTI